Amplifon stock gains 4.59 percent as margins improve in 2026

Published on 10/05/2026 at 23:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Amplifon stock was last at EUR 12.09 on October 5, 2026, up 4.59 percent. First-half revenue reached EUR 1.1857 billion and Q2 margin rose to 25.8 percent.

Flatlay mit Aktienzertifikat, ISIN-Karte und kleinem Hörgerät auf Holztisch — Flatlay-Arrangement mit Aktienzertifikat und Hörgerät illustriert Investment in Amplifon S.p.A., ISIN IT0004056880, dem Hörgeräte-Marktführer, Illustration mit AI erstellt.

Amplifon stock (ISIN IT0004056880) was last at EUR 12.09 on Euronext Milan on October 5, 2026, at 5:35 p.m. CEST, up 4.59 percent on the session. The move comes as the hearing-care group enters the final weeks before its next results date, with operating figures showing stronger margins in the first half of 2026.

First-half growth reaches 3.5 percent

Amplifon reported first-half 2026 revenue of EUR 1.1857 billion, up 1.3 percent at constant exchange rates, while organic growth reached 3.5 percent, according to Capital.com in its September 30, 2026 analysis. Second-quarter organic growth accelerated to 4.7 percent, giving the company its strongest quarterly growth rate in two years.

The profitability trend was more pronounced than the revenue increase. Adjusted EBITDA reached EUR 298.0 million in the first half, up 3.6 percent year over year, while the adjusted EBITDA margin rose to 25.1 percent; in the second quarter, the margin reached 25.8 percent, up 0.9 percentage points from the prior year, Capital.com reported.

Analyst target stays above EUR 13

The consensus published by Investing.com covers 16 analysts and carries an overall Buy rating, with seven Buy ratings, nine Holds and zero Sells. The average 12-month price target is EUR 13.625, with estimates ranging from EUR 11.1 to EUR 16.7.

At EUR 12.09, the average target lies 12.7 percent above the October 5 price. That spread gives the stock a clear valuation checkpoint, while the wide EUR 5.6 gap between the low and high targets shows how differently analysts assess the combination of improving margins and the planned GN Hearing transaction.

October 29 brings two checkpoints

Amplifon has scheduled its third-quarter 2026 results presentation for October 29, 2026, according to the Amplifon corporate calendar. The company has also published a notice for a shareholders meeting on the same date, linking the operating update with decisions related to the GN Hearing acquisition.

For investors, the next report will test whether the 4.7 percent second-quarter organic growth rate and the 25.8 percent adjusted EBITDA margin can be sustained. The acquisition adds a second measurement point because financing, share issuance and integration progress will shape the earnings profile alongside underlying hearing-care demand.

Amplifon stock holds below yearly high

Amplifon stock was last at EUR 12.09 on October 5, 2026, with a 52-week range of EUR 7.84 to EUR 15.84. The latest price is 23.7 percent below the yearly high, while the company's market capitalization stood at EUR 2.7 billion and trading volume reached 1,635,894 shares.